View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0925-0613
ICR Reference No:
201901-0925-002
Status:
Historical Active
Previous ICR Reference No:
201602-0925-006
Agency/Subagency:
HHS/NIH
Agency Tracking No:
18857
Title:
Investigational Agent Accountability Record Forms in the Conduct of Investigational Trials in Cancer Treatment (NCI)
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
03/14/2019
Retrieve Notice of Action (NOA)
Date Received in OIRA:
02/01/2019
Terms of Clearance:
OMB is approving this information collection request for a period of three years during which time the agency will request approval to extend or revise the collection if the agency seeks to continue the information collection activity beyond the period approved under this action.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
03/31/2022
36 Months From Approved
03/31/2019
Responses
45,504
0
119,457
Time Burden (Hours)
3,033
0
14,649
Cost Burden (Dollars)
0
0
0
Abstract:
This information collection is a revision for a three-year period. The U.S. Food and Drug Administration (FDA) holds the National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis/Cancer Therapy Evaluation Program (NCI/DCTD/CTEP) and the Division of Cancer Prevention (DCP) responsible, as a sponsor of investigational drug trials, to assure the FDA that systems for accountability are being maintained by investigators in its clinical trials program. Data obtained from the Investigational Agent Accountability Record Forms are used to track the dispensing of investigational anticancer agents from receipt from the NCI to dispensing or administration to patients.
Authorizing Statute(s):
US Code:
21 USC 312.62
Name of Law: Public Health Service Act
US Code:
21 USC 312.64
Name of Law: Public Health Service Act
US Code:
21 USC 312.58
Name of Law: Public Health Service Act
US Code:
21 USC 312.53
Name of Law: Public Health Service Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
83 FR 53885
10/25/2018
30-day Notice:
Federal Register Citation:
Citation Date:
84 FR 785
01/31/2019
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
2
IC Title
Form No.
Form Name
Drug Accountability Record Form (DARF and DARF-Oral)
7, 8
Attach 1 DARF Agent accountability
,
Attach 2 DARF Oral agent agent accountability
Drug Accountability Record Form (DARF)
1
Investig Agent Account Record
Drug Accountability Record Form - Oral Version (DARF- Oral)
2
Investig Agent-Oral Account Record
Financial Disclosure Form (Attachments 5A or 5B)
6, 5
Attach 5 Financial Disclosure Form
,
Attach 5B Financial Disclosure DCP
Statement of Investigator Attachments 3A or 3B
1, 2
Attach 3A NCI Modified FDA form 1572
,
Attach 3B Statement of Investigator DCP copy
Supplemental Investigator Data Form (Attachment 4)
3
Attach 4 Supplemental Investigator data form
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
45,504
119,457
0
-73,953
0
0
Annual Time Burden (Hours)
3,033
14,649
0
-11,616
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Miscellaneous Actions
Short Statement:
The investigator registration process underwent a technology change from paper data collection to electronic data collection. The use of the electronic forms for investigator registration information collection were approved under the CTEP Branch and Support Contracts Forms and Surveys submission (OMB No. 0925-0753) with an expiration date of 7/31/2021. Therefore, removing the investigator registration forms from this submission has decreased the total burden by 11,142 hours. In addition, this submission requests a reduction of 474 fewer burden hours than the 2016 submission because there is a year to year variation in the number of active studies (and subsequently the number of patients enrolled in those studies).
Annual Cost to Federal Government:
$23,524
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
Yes
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Tawanda Abdelmouti 240 276-5530 ta401@nih.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
02/01/2019
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.